This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Dermatology  • Dermatologic Disorders  • Bullous Diseases  • Randomized Controlled Trial  • Pemphigoid  • Dermatology, Other  • Immunology  • Immunologic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Arch Dermatol. 2002;138:1236-1237.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A comparison of oral and topical corticosteroids in patients with bullous pemphigo
Joly P, Roujeau JC, Benichou J, et al
N Engl J Med. 2002;346:321-327

Joly and colleagues have conducted a clinical trial that has important implications for the management of patients with bullous pemphigoid. The study was a multicenter, randomized, nonblinded trial in which patients were stratified based on the severity of disease and clinical center prior to randomization. The study population consisted of consecutive patients with bullous pemphigoid based on clinical features, a subepidermal blister on skin biopsy, and linear deposits of IgG and C3 along the basement membrane zone. Patients were excluded if there was predominant or exclusive mucous membrane involvement, or if the patient had been treated with oral or topical corticosteroids, dapsone, or immunosuppressive drugs in the previous 6 months. Patients were defined as having extensive disease if they had more than 10 new . . . [Full Text of this Article]

Comment



CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?